Abstract
Thyroid-stimulating-hormone-alpha (TSH-α) is the common subunit of the heterodimeric hormone TSH and also of other glycoprotein hormones. Although both expression and promoter-methylation profiles of the gene have been observed in the pituitary gland and placenta, no observation has been reported in the thyroid gland. We examined TSH-α expression in normal and cancer thyroid tissues. Keal-time RT-PCR and immunohistochemistry indicated that TSH-α was repressed in normal tissues while activated in cancer tissues. To identify the epigenetic mechanism of upregulation of TSH-α, the methylation status of the seven CpG sites in the TSH-α promoter was examined in sixty thyroid cancer tissues. Two CpG sites showed remarkably higher levels of methylation in cancer (46 and 45%) than in normal tissues (24 and 23%) (p=0.010 and 0.003). These findings indicate that TSH-α is expressed in the thyroid cancer tissue per se and that its expression can be affected by promoter methylation.
| Original language | English |
|---|---|
| Pages (from-to) | 341-347 |
| Number of pages | 7 |
| Journal | Genes and Genomics |
| Volume | 31 |
| Issue number | 5 |
| DOIs | |
| State | Published - Oct 2009 |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Keywords
- CpG islands
- Epigenetics
- Methylation
- Thyroid cancer
- Thyroid-stimulating hormone
Fingerprint
Dive into the research topics of 'Promoter hypermethylation and up-regulation of thyroid-stimulating-hormone- alpha (TSH-α) in thyroid cancer'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver